Last Updated -

October 26, 2026

Oklo

Company Profile and Market Insights

Explore the business model, global strategy, and market performance including insights into its position in China.

Oklo
Key facts
Founded 2013 • NYSE: OKLO • Q2 2026 results (quarter ended Jun 30, 2026)
$3.006bn
Cash, cash equivalents & marketable securities (Jun 30, 2026)
$1.210m
Q2 2026 revenue
$48.536m
Q2 2026 net loss
$0.28
Q2 2026 diluted EPS loss
$39.474m
Q2 2026 R&D expense
$65.459m
H1 2026 operating cash used

About

Oklo Inc. is a Santa Clara, California-based advanced nuclear company developing small fast-fission power plants, nuclear fuel recycling and fabrication capabilities, and domestic radioisotope production. Its planned core product is the Aurora Powerhouse, a compact nuclear plant designed to provide clean firm power, meaning electricity available around the clock rather than only when weather conditions allow. The company is pre-commercial in its main reactor and fuel-cycle businesses, with no Aurora plant yet generating commercial power revenue.

‍

Oklo has developed from a reactor developer into a more vertically integrated advanced nuclear platform. Its strategy spans reactor deployment, recycling used nuclear fuel and other nuclear materials into usable reactor fuel, producing radioisotopes for medical, industrial, space, defense, research, and national-security uses, and owning specialized engineering and manufacturing capacity. In June 2026, Oklo acquired ARMEC and Creative Engineers, adding precision manufacturing, prototyping, mechanical engineering, and sodium and alkali-metal process expertise.

‍

Oklo reported its first revenue in Q2 2026, with $1.210 million generated mainly from acquired engineering, consulting, manufacturing, and fabrication services. The company remains in a heavy investment phase, with a Q2 2026 net loss of $48.536 million and R&D expense of $39.474 million. At June 30, 2026, Oklo held $3.006 billion in cash, cash equivalents, and marketable debt securities, giving it substantial funding for reactor, fuel, isotope, and operating plans. Recent milestones include first criticality at the Groves Isotope Test Reactor in Texas and selection of Groves-2 Forge for a DOE-backed isotope irradiation and processing pilot facility.

Oklo

Business Model and Market Position

Oklo is a development-stage advanced nuclear company. Its core plan is to deploy small fast-fission power plants under the Aurora Powerhouse brand, build related nuclear fuel recycling and fabrication capabilities, and develop domestic radioisotope production. The company reports one operating segment, so investors should view the business as an integrated advanced nuclear platform rather than a set of separately reported divisions.

‍

Oklo is not yet earning power revenue from an operating Aurora plant. In Q2 2026, the company reported $1.210 million of revenue, compared with no revenue in Q2 2025. Most of that revenue came from acquired engineering and manufacturing subsidiaries, with $0.800 million from engineering and consulting services, $0.168 million from manufacturing and fabrication services, and $0.242 million from other revenue.

‍

The intended business model has three main layers

‍

  1. Aurora powerhouses: Oklo aims to own or deploy fast-fission power plants that provide firm clean electricity. This model differs from selling only reactor equipment, since future economics are tied to project deployment, licensing, fuel supply, and long-term power demand.
  2. Fuel-cycle integration: The company is developing recycling and fabrication capabilities designed to convert used nuclear fuel and other nuclear materials into usable reactor fuel. This is strategically important because fuel availability is a major bottleneck for advanced reactors.
  3. Radioisotopes and specialized engineering: Oklo is building a radioisotope business for medical, industrial, space, defense, research, and national-security uses. Its June 2026 acquisitions of ARMEC and Creative Engineers added precision manufacturing, prototyping, mechanical engineering, and sodium and alkali-metal process capabilities that also serve government and commercial customers.

‍

Oklo’s market position is early but differentiated. It operates in the advanced nuclear and small modular reactor ecosystem, yet it has no commercial Aurora power plant in service. Its value proposition rests on faster, smaller, fuel-flexible reactor deployment paired with a more vertically integrated fuel and manufacturing strategy.

‍

The company’s competitive advantages include several first-mover claims and strategic assets

‍

  1. Regulatory positioning: Oklo highlights the first Department of Energy site-use permit for a commercial advanced fission plant and the first custom combined license application for an advanced reactor submitted to the U.S. Nuclear Regulatory Commission.
  2. U.S. project footprint: The company identifies deployment activity in Alaska, Idaho, Ohio, Tennessee, and Texas, keeping its disclosed commercial and regulatory pathway heavily U.S.-focused.
  3. Vertical integration: Oklo is developing reactor deployment, fuel recycling, fuel fabrication, isotope production, and specialized manufacturing capabilities within one platform.
  4. Balance sheet support: As of June 30, 2026, Oklo held $3.006 billion of cash, cash equivalents, and marketable debt securities, giving it substantial funding for development work relative to many early-stage nuclear peers.
  5. Adjacent isotope progress: The Groves Isotope Test Reactor in Texas reached first criticality in August 2026, and Groves-2 Forge was selected in October 2026 under the DOE and NRIC Nuclear Energy Launch Pad initiative, with an initial focus on lutetium-177.

‍

Oklo’s direct competitors include other advanced nuclear and small modular reactor developers, established reactor vendors, nuclear utilities, and companies pursuing alternative firm clean power technologies. A useful U.S.-listed comparison is NuScale Power, another public advanced nuclear developer. NuScale’s technology and commercialization approach differ from Oklo’s fast-reactor and fuel-cycle model, but both companies compete for investor capital, utility and industrial customer attention, government support, and regulatory credibility in the emerging small reactor market.

‍

Oklo remains pre-commercial for its central Aurora power business. The company’s Q2 2026 net loss was $48.536 million, and first-half 2026 net cash used in operating activities was $65.459 million. Its current market position therefore depends less on present revenue scale and more on whether it converts technical, licensing, fuel, isotope, and project-development milestones into operating assets and long-term contracted demand.

Oklo

Performance in China

China is not a meaningful disclosed market for Oklo. The company’s latest Q2 2026 filing does not identify China revenue, customers, projects, suppliers, manufacturing assets, or regulatory exposure. Oklo is primarily a U.S.-focused advanced nuclear developer, with activity centered on Aurora powerhouse deployment, fuel recycling and fabrication, radioisotopes, and specialized engineering and manufacturing. Its disclosed project footprint is in Alaska, Idaho, Ohio, Tennessee, and Texas, while its partnerships are concentrated around U.S. national laboratories, the Department of Energy, Battelle Energy Alliance, INL, Los Alamos, Argonne, and NVIDIA-related modeling work. Q2 2026 revenue was $1.210 million, mainly from acquired U.S. engineering, consulting, manufacturing, and fabrication subsidiaries, rather than reactor power sales. China’s main relevance is as a global nuclear competitor, not a current Oklo operating market.

Growth and Future Prospects

Oklo is still a development-stage advanced nuclear company, but 2026 marked a shift from a purely pre-revenue profile to a company with early operating revenue from acquired engineering and manufacturing units. In Q2 2026, revenue was $1.210 million, compared with no revenue in Q2 2025, mainly from engineering and consulting services, manufacturing and fabrication services, and other revenue. The larger financial story remains investment and losses. Q2 2026 net loss was $48.536 million, and net cash used in operating activities was $65.459 million in the first half of 2026. Oklo’s balance sheet is unusually large for its stage, with $3.006 billion of cash, cash equivalents, and marketable debt securities at June 30, 2026.

‍

Key growth drivers

‍

  1. Advanced nuclear demand: Demand for reliable clean power from AI data centers, industrial electrification, energy security, and grid reliability supports the long-term case for small advanced reactors, provided Oklo obtains licenses and executes projects.
  2. Fuel-cycle integration: Oklo is pursuing fuel recycling and fabrication capabilities, including DOE-related work for the Aurora Fuel Fabrication Facility and fuel pilot programs. This addresses one of the main bottlenecks for fast-reactor deployment.
  3. Radioisotopes: The Groves Isotope Test Reactor reached first criticality in August 2026, and Groves-2 Forge was selected for a DOE/NRIC launch pad initiative. These projects give Oklo an adjacent path focused on domestic isotope production, including lutetium-177.
  4. Manufacturing and engineering depth: The June 2026 acquisitions of ARMEC and Creative Engineers added precision manufacturing, prototyping, sodium, and alkali-metal process capabilities. These businesses also generated most Q2 2026 revenue.
  5. Technical partnerships: Work with DOE laboratories, Battelle Energy Alliance, INL, Argonne, Los Alamos, and NVIDIA-related AI modeling workflows supports reactor design, fuel validation, simulation, and documentation efficiency.

‍

Geographic expansion remains primarily U.S.-focused. Oklo’s disclosed project footprint includes Alaska, Idaho, Ohio, Tennessee, and Texas, with no meaningful China exposure disclosed in the latest filing. Product expansion is centered on three connected areas: Aurora powerhouses, nuclear fuel recycling and fabrication, and radioisotopes.

‍

Challenges ahead

‍

  1. Licensing and execution risk: No commercial Aurora powerhouse is in service. Nuclear licensing, safety reviews, construction, fuel qualification, and public acceptance remain critical hurdles.
  2. Cash burn and capital needs: R&D expense rose to $39.474 million in Q2 2026 from $11.468 million a year earlier. Large-scale deployment of reactors, fuel facilities, and isotope infrastructure is capital intensive.
  3. Technical complexity: Fast reactors, recycled nuclear fuel, plutonium-bearing materials, isotope processing, and alkali-metal systems carry regulatory, security, supply-chain, and cost risks.

‍

Oklo’s outlook depends less on current revenue growth and more on whether it converts its cash balance, DOE relationships, acquisitions, and fuel-cycle strategy into licensed, operating assets. The company has meaningful strategic momentum, but its valuation remains tied to future execution rather than present earnings.

Next Earnings Planned for:

November 6, 2026

This Company Profile was written by Dominik Diemer

Dominik Diemer blends an investor mindset with execution discipline.

He is a SAFe Program Consultant (SPC) and Lean Portfolio Management (LPM) practitioner at DMG MORI Digital, working as a SAFe Release Train Engineer and internal consultant in the Lean-Agile Center of Excellence (LACE).

His focus is prioritization, flow, and dependency management that turns strategy into outcomes. With experience across Bertelsmann and the Founders Foundation, he bridges corporate and startup thinking.

He also invests privately in private equity deals, sharpening his view on business models, value drivers, and go-to-market.

StockCounterParts reflects that lens.